FDA approves cell-based gene therapy to treat adults with relapsed or refractory large-B-cell lymphoma

Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with

Read more

Maxolon

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. MAXOLON® Metoclopramide hydrochloride Consumer Medicine Information What

Read more